The need for tailoring ovarian cancer treatments to individual patients is increasing. This study aimed to evaluate the prognostic value of pretreatment laboratory test data for predicting the response and survival outcomes of platinumbased chemotherapy in ovarian cancer.
CITATION STYLE
Ikeda, A., Yamaguchi, K., Yamakage, H., Abiko, K., Satoh-Asahara, N., Takakura, K., & Konishi, I. (2020). Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer. Obstetrics and Gynecology Science, 63(6), 709–718. https://doi.org/10.5468/OGS.20117
Mendeley helps you to discover research relevant for your work.